MedPath

Clinical study of Hair Oil formulation in Hair loss in females.

Phase 2
Completed
Conditions
Health Condition 1: null- Mild to moderate Hair loss in females
Registration Number
CTRI/2018/05/014122
Lead Sponsor
Emami Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

1.Female subjects between the age group of 18- 45 years both inclusive.

2.Subjects suffering from mild to moderate hair loss (40-140 Hair by Comb test and Finger Test).

3.Subjects who are infrequent hair oil users.

4.Subjects who are willing to give informed consent and ready to comply with the protocol.

5.Subjects who are ready to provide regular follow ups till the completion of the study.

Exclusion Criteria

1.Subjects with severe Hair fall due to any clinically significant disorder/s like anemia, thyroid disorders etc.

2.Subject with severe dermatological disorders of the scalp that might interfere with the study evaluation.

3.Subjects with recent disease history like malaria, typhoid, jaundice and scalp diseases and subjects who in the opinion of the investigator are not eligible for enrollment in the clinical study.

4.Subjects who have regularly used anti-hair fall treatment with hair oil over the last 6 months.

5.Subjects who have previously undergone hair transplantation procedures.

6.Subjects on systemic steroids for more than 14 days within 2 months prior to enrollment.

7.Subjects on immunosuppressive drugs.

8.Known cases of Hypersensitivity to hair oil contents.

9.Subjects who have participated in any other clinical study since last 3 months.

10.Subjects who are reported pregnant/planning a pregnancy or lactating.

11.Menopausal Women.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Assessment of hair fall by running finger test over a period of 60 days. <br/ ><br>2.Assessment of hair breakage by comb test over a period of 60 days <br/ ><br>Timepoint: Day -3, Day 0, Day 15, Day 30, Day 45, Day 60
Secondary Outcome Measures
NameTimeMethod
1.Assessments of hair fall by Hair Pull test. <br/ ><br>2.Assessment of hair growth by comparing against standard nonusers. <br/ ><br>3.Assessment of effect of hair oil on dandruff in females by standard dandruff evaluation strip. <br/ ><br>4.Assessment of effect of hair oil on quality of hair based on subject questionnaire. <br/ ><br>5.Global assessment for overall change in hair loss by the physician and subject. <br/ ><br>6.Assessment of safety by observing episodes, severity and duration of any allergic reactions and adverse events. <br/ ><br>Timepoint: Day -3, Day 0, Day 15, Day 30, Day 45, Day 60
© Copyright 2025. All Rights Reserved by MedPath